ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SBTX Skinbiotherapeutics Plc

15.875
-0.375 (-2.31%)
Last Updated: 15:11:01
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.375 -2.31% 15.875 15.50 16.25 16.25 15.625 16.25 408,238 15:11:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 132k -2.84M -0.0125 -12.50 36.74M
Skinbiotherapeutics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherapeutics was 16.25p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 7.25p to 20.00p.

Skinbiotherapeutics currently has 226,086,285 shares in issue. The market capitalisation of Skinbiotherapeutics is £36.74 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -12.50.

Skinbiotherapeutics Share Discussion Threads

Showing 27451 to 27470 of 27900 messages
Chat Pages: Latest  1104  1103  1102  1101  1100  1099  1098  1097  1096  1095  1094  1093  Older
DateSubjectAuthorDiscuss
05/11/2024
09:11
Perhaps they meant 5.5 ?
kreature
05/11/2024
09:03
Maker having a day off?
putinaire
04/11/2024
21:35
Sorry, buyers
putinaire
04/11/2024
21:35
Yes stunning publicity. The daily trade count average will rocket up,,

Sellers

putinaire
04/11/2024
21:27
200k was well worth it for entertainment purposes imv. Plus good publicity if any new investors want to consider getting shafted ?
kreature
04/11/2024
20:14
When you start getting into millions over time, translating to near term multi million pound losses, it all looks rather tempting

Be understandable if costs were real, but when you see others coming up with 200K legal bill for a coffee and a natter, you start to wonder

putinaire
04/11/2024
20:06
I was also going to tag revenue forecasts on to future years and earnouts etc, but im thinking JPM have it done already
putinaire
04/11/2024
20:02
Oh that JPM. yes about to sign it all off id say
putinaire
04/11/2024
20:01
JPM prob just doing the paperwork before investing millions here ?
kreature
04/11/2024
19:32
Great short price tbf.
putinaire
04/11/2024
19:07
Then il give mine based upon forecasted revenue growth using past estimated margins, and earnouts lol
putinaire
04/11/2024
19:04
June 2023 Loss for the year (2,835,149)
As of June 2023 - retained earnings (9,441,546)

Significant improvements in a few days?

Or, do we wait for that until H2 next year, as per norm?

Would anyone like to give me a forecast for the two above numbers re end of November 2024 AND Nov 2025

putinaire
04/11/2024
19:00
June 2023 Loss for the year (2,835,149)
As of June 2023 - retained earnings (9,441,546)

Ummmm the long term loss doesnt seem to be paying off recently

Better at the end of the month?

Listed April 2017

Would we get away with just calling it an acorn now? Transitioning> Into.,..something?...

putinaire
04/11/2024
18:40
Not sure but are certain flexible accounting treatments and JIT cash raises really a good way to say shareholder equity is not negative?

think bigger institutions would have a frown about that

putinaire
04/11/2024
18:34
Are we still in negative shareholder equity here?

I just saw a forecast of revenues growth expected at 160%. But when you look at past revenues and the costs , isnt that simply an increase in losses?

putinaire
Chat Pages: Latest  1104  1103  1102  1101  1100  1099  1098  1097  1096  1095  1094  1093  Older

Your Recent History

Delayed Upgrade Clock